Literature DB >> 7677777

Modulation of metallothionein-III mRNA content and growth rate of rat C6-glial cells by transfection with human 5-HT1D receptor genes.

M C Amoureux1, T Wurch, P J Pauwels.   

Abstract

The mRNA content of the brain-specific metallothionein-III (MT-III) protein was measured by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in two transformed glial cell lines: rat C6-glial and human U-373 MG cells. Low levels of MT-III mRNA were detected compared to a high expression of this mRNA in primary cultures of rat astrocytes. C6-glial cell lines stably transfected with a human 5-HT1D alpha or 5-HT1D beta receptor gene showed a decrease (87 to 93%) in basal [3H]thymidine incorporation, whereas their MT-III mRNA content was more than 30-fold increased compared to plasmid transfected C6-glial cells. The inverse proportion between mitogenic activity and MT-III mRNA content suggests that MT-III may act as a growth inhibitory factor in rat C6-glial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677777     DOI: 10.1006/bbrc.1995.2334

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Differential regulation by multiple promoters of the gene encoding the neuron-restrictive silencer factor.

Authors:  C Koenigsberger; J J Chicca; M C Amoureux; G M Edelman; F S Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis.

Authors:  M A Sens; S Somji; S H Garrett; C L Beall; D A Sens
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments.

Authors:  X L Yang; N Miura; Y Kawarada; K Terada; K Petrukhin; T Gilliam; T Sugiyama
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission.

Authors:  R A Velázquez; Y Cai; Q Shi; A A Larson
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

5.  Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation.

Authors:  Eric Smith; Paul A Drew; Zi-Qing Tian; Neville J De Young; Jun-Feng Liu; George C Mayne; Andrew R Ruszkiewicz; David I Watson; Glyn G Jamieson
Journal:  Mol Cancer       Date:  2005-12-13       Impact factor: 27.401

6.  Metallothionein isoform 3 as a potential biomarker for human bladder cancer.

Authors:  M A Sens; S Somji; D L Lamm; S H Garrett; F Slovinsky; J H Todd; D A Sens
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

7.  Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression.

Authors:  Alicja M Kmiecik; Bartosz Pula; Jaroslaw Suchanski; Mateusz Olbromski; Agnieszka Gomulkiewicz; Tomasz Owczarek; Anna Kruczak; Aleksandra Ambicka; Janusz Rys; Maciej Ugorski; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

8.  The unique C- and N-terminal sequences of Metallothionein isoform 3 mediate growth inhibition and Vectorial active transport in MCF-7 cells.

Authors:  Brent Voels; Liping Wang; Donald A Sens; Scott H Garrett; Ke Zhang; Seema Somji
Journal:  BMC Cancer       Date:  2017-05-25       Impact factor: 4.430

9.  Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.

Authors:  Hua Wei; Mohamed Mokhtar Desouki; Shufei Lin; Dakai Xiao; Renty B Franklin; Pei Feng
Journal:  Mol Cancer       Date:  2008-01-21       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.